ARTICLE
3 April 2020

COVID-19: Key Securities Law Impacts And Considerations For Public Life Sciences Companies (Video)

F
Fenwick

Contributor

Fenwick provides comprehensive legal services to leading technology and life sciences companies — at every stage of their lifecycle — and the investors that partner with them. For more than four decades, Fenwick has helped some of the world's most recognized companies become and remain market leaders. Visit fenwick.com to learn more.
The global spread of COVID-19 has impacted all aspects of business and raises significant securities law questions for public life sciences companies.
United States Coronavirus (COVID-19)

COVID-19 Key Securities Law Impacts and Considerations

from Fenwick & West on Vimeo.

​​The global spread of COVID-19 has impacted all aspects of business and raises significant securities law questions for public life sciences companies. In this video, Fenwick partners Rob Freedman and Amanda Rose discuss the securities law considerations that should be top of mind.​​

View the video and the  slide deck​ for this webinar.​​

​Topics covered include:

  • ​SEC​ Updates
  • Governance Considerations
  • IR/PR Considerations
  • Periodic Reporting Considerations
  • Financing Considerations

You can access additional webinars, videos, alerts and articles at Fenwick's COVID-19 Resource Center.

​​

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More